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Ultralow-intensity near-infrared light induces drug
delivery by upconverting nanoparticles†
Shuqing He,a Kristina Krippes,a Sandra Ritz,a Zhijun Chen,a Andreas Best,a
Hans-Ju¨rgen Butt,a Volker Maila¨nderab and Si Wu*a
Mesoporous silica coated upconverting nanoparticles are loaded with
the anticancer drug doxorubicin and grafted with ruthenium complexes
as photoactive molecular valves. Drug release was triggered by 974 nm
light with 0.35 W cm2. Such low light intensity minimized overheating
problems and prevented photodamage to biological samples.
Light has been used for therapy for thousands of years. In modern
nanomedicine, light is used to trigger drug release from photo-
sensitive nanocarriers.1 For most photosensitive nanocarriers, photo-
reactions are induced by UV or visible light.1 Compared to UV and
visible light, near-infrared (NIR) light is more suitable for biomedical
applications since NIR light is able to penetrate deeper into tissues
and causes less damage. One approach to achieve NIR-triggered
drug release is to use simultaneous two-photon absorption to
induce photoreactions in nanocarriers. However, this approach
is inefficient even when high-intensity femtosecond lasers (pulse
intensity4106 W cm2)2 are used because of the low two-photon
absorption cross sections of typical chromophores.
An alternative approach to achieve NIR light-triggered drug
release is based on lanthanide-doped upconverting nanoparticles
(UCNPs).3 UCNPs convert NIR light (B980 nm) to UV and visible
light that can subsequently trigger useful photoreactions (Fig. 1a).
This process is called UCNP-assisted photochemistry (Fig. 1a).3d
Compared to simultaneous two-photon absorption, UCNPs can be
excited by continuous-wave NIR laser diodes with relatively low
intensity. There are two requirements for UCNP-assisted photo-
chemistry. First, upconversion requires an excitation intensity which
exceeds a certain threshold.4 Second, a suitable photosensitive
compound absorbs upconverted light. The reported excitation
intensity for UCNP-assisted photochemistry is usually several to
several hundred W cm2 (Table S1, ESI†).3b,c,e,5 However, according
to the American national standard for safe use of lasers, NIR lasers
with the intensity of several W cm2 are dangerous.6 Under con-
tinuous exposure to 980 nm light, the maximum permissible
exposure of skin is 0.726 W cm2.6 High-intensity NIR light
can cause overheating problems and photodamage to biological
samples. For example, the overheating effect induced by 980 nm
light at 6 W cm2 can cause cell death within 5 min.7 The required
Fig. 1 (a) Schematic illustration: upconverting nanoparticles (UCNPs)
convert near-infrared (NIR) light to UV or visible light, which induces
photoreactions of photosensitive compounds. (b) UV/Vis absorption spec-
tra of five widely used photosensitive compounds. Inset: chemical struc-
ture of the Ru complex (Ru1). (c) Emission spectra (lex = 974 nm) of
NaYF4:TmYb@NaYF4 UCNPs under different excitation intensities. The
emission intensity is normalized at 470 nm.
aMax Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz,
Germany. E-mail: wusi@mpip-mainz.mpg.de
b III. Medical Clinic, University Medicine of the Johannes-Gutenberg University Mainz,
Langenbeckstr. 1, 55131 Mainz, Germany
† Electronic supplementary information (ESI) available. See DOI: 10.1039/
c4cc07489k
Received 22nd September 2014,


























































































View Journal  | View Issue
432 | Chem. Commun., 2015, 51, 431--434 This journal is©The Royal Society of Chemistry 2015
high excitation intensity of UCNP-assisted photochemistry hinders
its biomedical applications. To prevent damage to biological
samples due to the NIR laser, it is highly desirable to reduce the
light intensity for UCNP-assisted photochemistry.
Herein, we demonstrate a strategy to reduce the NIR light
intensity for UCNP-assisted photochemistry to a medically harmless
dose. We show that 974 nm light with 0.35W cm2 is able to trigger
drug release based on UCNP-assisted photochemistry. To the best of
our knowledge, 0.35 W cm2 is the lowest reported intensity for
UCNP-assisted photochemistry (Table S1, ESI†). This light intensity
is also lower than the maximum permissible exposure of skin
(0.726 W cm2). Overheating problems are minimized and photo-
damage to biological samples is prevented at such a low light
intensity. We fabricated a drug delivery system by loading of
mesoporous silica coated UCNPs with doxorubicin. As photoactive
molecular valves, blue-light-cleavable ruthenium (Ru) complexes are
grafted to the surface of the nanoparticles. The required NIR
intensity was that low because a three-photon process is sufficient
to create the required blue photons and to induce the photocleavage
of Ru complexes. Usually, a four-photon NIR-to-UV upconversion is
applied to induce photoreactions of UV-sensitive compounds.
The concept in UCNP-assisted photochemistry entails that a
photosensitive compound absorbs the upconverted light. Therefore,
the absorption of photosensitive compounds should overlap with
the emission of UCNPs (Fig. 1a). We studied absorption of five
commonly used photosensitive compounds (Fig. 1b); their chemical
structures are shown in Fig. S1 (ESI†). The metal-to-ligand charge
transfer band of the Ru complex (Ru1) is at B453 nm (Fig. 1b).
Photocleavage of Ru1 can be induced by blue light (Fig. S12, ESI†).8
Like most reported photosensitive compounds,1 the absorption
bands of the other four compounds are in the UV region. Their
photoreactions are induced by UV light.
We synthesized b-phase NaYF4:TmYb@NaYF4 UCNPs (core =
NaYF4:0.5 mol% Tm
3+: 30 mol% Yb3+; shell = NaYF4) (Fig. S2–S5,
ESI†), which are some of the most efficient UCNPs known to date.9 At
high excitation intensities (Z5.48 W cm2) with a 974 nm laser, the
UCNPs emit both blue and UV light (Fig. 1c). At low excitation
intensities (0.19–0.81 W cm2), only blue light is emitted (Fig. 1c).
The relative intensity of the emission depends on the excitation
intensity because the photon numbers for excitation of different
emissions vary.10 The excitation thresholds for 1I6–
3F4 transition
(340 nm, a five-photon process10), 1D2–
3H6 transition (360 nm, a four-
photon process10), and 1G4–
3H6 transition (470 nm, a three-photon
process10) are 5.48, 2.22, and 0.19 W cm2, respectively (Fig. 1c
and Fig. S6, ESI†). Thus, blue emission at 470 nm still retains and
UV emission completely vanishes at excitation intensities below
2.22 W cm2 and above 0.19 W cm2. Out of the five photo-
sensitive compounds, the upconverted blue light at 470 nm over-
laps with the absorption band of Ru1 only (Fig. 1b and c).
Therefore, it is only possible to excite the photoreaction of Ru1
at low excitation intensity e.g. 0.35 W cm2.
Based on our hypothesis, we prepared a NIR light-triggered drug
delivery system by grafting mesoporous silica coated UCNPs with
Ru1 (Fig. 2). UCNPs were coated with mesoporous silica (UCNP@
mSiO2) by a sol–gel reaction.
11 The mesoporous silica is the drug
carrier.11 The grafted Ru complexes act as molecular valves.12
The average diameter of UCNP@mSiO2 measured by TEM and
dynamic light scattering was 92 nm and 89 nm, respectively
(Fig. 2a and Fig. S2 and S3, ESI†). The average thickness of the
mesoporous silica shell was 21 nm (Fig. S2, ESI†). Powder X-ray
diffraction confirmed that the UCNPs are hexagonal in phase
(Fig. S4, ESI†). The average pore size and the Brunauer–Emmett–
Teller (BET) surface area of UCNP@mSiO2 were 2.6 nm and
316 m2 g1, respectively (Fig. S7, ESI†). UCNP@mSiO2 nano-
particles were loaded with the anticancer drug doxorubicin and
grafted with Ru1 to form DOX-UCNP@mSiO2-Ru (Fig. 2b). The
drug loading efficiency, measured by fluorescence spectroscopy
and UV/Vis absorption spectroscopy, was 2.36% and 2.52%
(23.6 and 25.2 mg doxorubicin in 1 mg nanoparticles), respec-
tively (Fig. S17, ESI†). The successful grafting of UCNP@mSiO2
with Ru1 was confirmed by 29Si MAS solid-state NMR spectro-
scopy, UV/Vis absorption spectroscopy and FTIR spectroscopy
(Fig. S8–S10, ESI†). UV/Vis absorption spectroscopy shows that
7.6 mg Ru1 was grafted on 1 mg of nanoparticles (Fig. S11, ESI†).
To demonstrate absorption of upconverted blue light by the Ru
complex, we compared upconversion luminescence spectra of UCNP@
mSiO2 to UCNP@mSiO2-Ru (Ru1 grafted UCNP@mSiO2) nano-
particles. The intensity of upconversion luminescence at 470 nm
decreased significantly in the spectrum of UCNP@mSiO2-Ru (Fig. 3a).
Fig. 2 (a) Schematic model and TEM image of UCNP@mSiO2 nanoparticles.
(b) Schematic illustration: upconverted blue luminescence triggers cleavage
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In contrast, the emission atB800 nm, a spectral region where the
Ru complex has no absorption, still remained. This result proved
efficient absorption of the upconverted blue light by the Ru
complex. UV/Vis absorption spectroscopy further confirmed that
upconverted blue light can trigger cleavage of the Ru complex
(Fig. 3b). 974 nm light induced a slight redshift of the absorption
band of the Ru complex on UCNP@mSiO2-Ru (Fig. 3b). This
spectral change is identical to observations for solutions of Ru1 or
similar Ru complexes which were exposed to blue light to directly
trigger photocleavage (Fig. S12, ESI†).8b,c Exposure of Ru1 to
974 nm light in the absence of UCNPs had no influence on the
absorption spectrum (Fig. S13, ESI†), thus demonstrating that the
photocleavage of the Ru complex is triggered by upconversion.
Measurements by UV/Vis absorption spectroscopy showed that
974 nm light (0.35 W cm2) cleaved 59% Ru complexes from
UCNP@mSiO2-Ru after 5 hour irradiation (Fig. S14, ESI†).
NIR light-triggered drug release from doxorubicin loaded nano-
particles DOX-UCNP@mSiO2-Ru was studied by ‘‘mini dialysis’’
(Fig. S19, ESI†). Release of doxorubicin was not detected without
NIR irradiation. Approximately 42% of doxorubicin was released
after 974 nm light irradiation with 0.35W cm2 for 5 hours (Fig. 3c).
The release rate increased andB78% of doxorubicin was released
after 974 nm light irradiation with 0.64 W cm2 for 5 hours.
As a control experiment, UCNP@mSiO2 nanoparticles are grafted
with a UV-sensitive azobenzene compound instead of the Ru complex
(Fig. S30, ESI†). The control experiment showed that no drug release
from the azobenzene-grafted nanoparticles could be induced by
974 nm light with 0.35 W cm2. Approximately 27% of doxorubicin
was released after 974 nm light irradiation with 7W cm2 for 5 hours
(Fig. S30, ESI†). This result shows that the required light intensity for
drug release in DOX-UCNP@mSiO2-Ru is much lower. Thus, combin-
ing blue-light sensitive Ru complexes with UCNPs could efficiently
reduce the excitation intensity for UCNP-assisted photochemistry.
Encouraged by the successful drug release, we investigated NIR-
induced drug delivery in cancer cells. For all drug release and cell
culture experiments, nanoparticles weremodified with poly(ethylene
glycol) (PEG) and folic acid (FA) to enhance uptake by HeLa cells.13
TEM analyses demonstrated retention of nanoparticle morphology
after surface modification (Fig. S15, ESI†). In cellular studies, HeLa
cells were incubated with fluorescence-labeled UCNP@mSiO2-Ru
nanoparticles for 3–6 hours before irradiation. Confocal laser scan-
ning microscopy confirmed uptake of nanoparticles by HeLa cells
(Fig. 4a and Fig. S21, ESI†). Incubation of HeLa cells with UCNP@
mSiO2, UCNP@mSiO2-Ru or the doxorubicin loaded nanoparticles
(DOX-UCNP@mSiO2-Ru) in the dark did not cause a decrease of cell
viability, hereby excluding leakage or non-incorporated doxorubicin
(Fig. S22, ESI†). This result is in accordance with the extracellular
drug release profile which states that nearly no drugs can be released
from the nanoparticles without irradiation (Fig. 3c).
Subsequently, we exposed HeLa cells, incubated for 3–6 h with
DOX-UCNP@mSiO2-Ru, to 974 nm light with 0.35 mW cm
2. After-
wards, the cells were incubated further for 24 hours. NIR irradiation
of DOX-UCNP@mSiO2-Ru significantly inhibited the growth of
Fig. 3 (a) Emission spectra (lex = 974 nm, 0.35 W cm
2) of UCNP@mSiO2 and
Ru1 grafted UCNP@mSiO2 (UCNP@mSiO2-Ru) nanoparticles. Inset: photograph
of UCNP@mSiO2 (left) andUCNP@mSiO2-Ru (right) nanoparticles upon a 974 nm
laser exposure. The concentration of Ru complexes in UCNP@mSiO2-Ru was
higher than that in DOX-UCNP@mSiO2-Ru. (b) UV/Vis absorption spectra of
UCNP@mSiO2-Ru upon 974 nm light exposure (0.35 W cm
2). (c) Doxorubicin
release profile for PEG- and FA-modified DOX-UCNP@mSiO2-Ru nanoparticles
in the dark and upon 974 nm light exposure. The release profile wasmeasured by
fluorescence spectroscopy (Fig. S19, ESI†).
Fig. 4 (a) Confocal laser scanning microscopy image: fluorescence-labeled
UCNP@mSiO2-Ru nanoparticles are taken up by HeLa cells. The nucleus,
nanoparticles, and cell membrane are pseudocoloured in blue, green, and
red, respectively. The small images on the right side and at the bottom are
viewed from yz and xz plains. (b) Effects of light exposure (974 nm, 0.35Wcm2)
on the viability of HeLa cells in the presence of PEG- and FA-modified DOX-
UCNP@mSiO2-Ru and UCNP@mSiO2-Ru nanoparticles. Control: cells in the
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cancer cells (Fig. 4b). Irradiation for 10–30 min reduced cell viability
to a value of 40–29%. For comparison, control experiments under
identical conditions using UCNP@mSiO2-Ru, UCNP@mSiO2 or no
nanoparticles instead of DOX-UCNP@mSiO2-Ru were extensively
performed (Fig. 4b and Fig. S23 and S24, ESI†): NIR light irradiation
did not cause significant decrease of cell viability for these control
samples demonstrating that cytotoxicity to cancer cells (Fig. 4b) was
caused by release of doxorubicin.
We also studied the photothermal effect of 974 nm light by
exposure of water to the laser. The water temperature increased
only 2.5 1C upon irradiation of 974 nm light under 0.35 W cm2.
In contrast, irradiation of 974 nm light under 2 W cm2 causes a
temperature increase of 14 1C (Fig. S20, ESI†). This result
demonstrates that low NIR intensity can minimize overheating
problems caused by NIR light.
We tested the amount of photodamage of pork tissue under
974 nm light irradiation for 20 min (Fig. S27, ESI†). Serious
burn wounds were observed when the light intensity is higher
than 3 W cm2. When the light intensity is lower than 1 W cm2,
no obvious burn wound was observed. Therefore, using low-
intensity NIR light is important to prevent tissue damages.
We verified if low-intensity 974 nm light could induce drug delivery
after passing through tissue. We placed a pork tissue between the
laser and the nanoparticles. Approximately 26% of doxorubicin was
released after 974 nm light irradiation with 0.64 W cm2 for 5 hours
(Fig. 5b). The released doxorubicin also inhibited the growth of cancer
cells (Fig. 5c). The used light intensity (0.64W cm2) is also lower than
the maximum permissible exposure of skin (0.726 W cm2). Thus,
low-intensity NIR light could be used to trigger drug delivery and
minimize tissue damage in our system.
In conclusion, we demonstrate a strategy to reduce excitation
intensity for UCNP-assisted photochemistry. The reported concept
for constructing photoresponsive systems that are sensitive to
ultralow-intensity NIR light is novel and should be generally applic-
able to various biomedical applications. We apply this novel concept
for low-intensity NIR light-triggered drug delivery. Ru complexes on
UCNP@mSiO2-Ru nanoparticles are cleaved by 974 nm light with
intensity as low as 0.35 W cm2. Comparing UCNP@mSiO2-Ru to
other recently developed systems based on UCNP-assisted photo-
chemistry shows that 0.35W cm2 is the lowest intensity reported to
the best of our knowledge (Table S1, ESI†). In particular, the
intensity is lower than the maximum permissible exposure of skin
(0.726 W cm2). We expect the suitability of not only Ru complexes
but also other blue-light-sensitive compounds for UCNP-assisted
photochemistry with low excitation intensity.14 Low excitation inten-
sity in UCNP-assisted photochemistry minimizes the overheating
effect and causes less photodamage to biological samples, both of
which are important for biomedical applications.
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